ACME Laboratories Balance Sheet Health
Financial Health criteria checks 2/6
ACME Laboratories has a total shareholder equity of BDT23.8B and total debt of BDT22.2B, which brings its debt-to-equity ratio to 93.1%. Its total assets and total liabilities are BDT53.6B and BDT29.7B respectively. ACME Laboratories's EBIT is BDT5.1B making its interest coverage ratio 2.9. It has cash and short-term investments of BDT2.3B.
Key information
93.1%
Debt to equity ratio
৳22.18b
Debt
Interest coverage ratio | 2.9x |
Cash | ৳2.28b |
Equity | ৳23.82b |
Total liabilities | ৳29.74b |
Total assets | ৳53.56b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACMELAB's short term assets (BDT23.4B) exceed its short term liabilities (BDT21.3B).
Long Term Liabilities: ACMELAB's short term assets (BDT23.4B) exceed its long term liabilities (BDT8.5B).
Debt to Equity History and Analysis
Debt Level: ACMELAB's net debt to equity ratio (83.5%) is considered high.
Reducing Debt: ACMELAB's debt to equity ratio has increased from 71.3% to 93.1% over the past 5 years.
Debt Coverage: ACMELAB's debt is not well covered by operating cash flow (4.7%).
Interest Coverage: ACMELAB's interest payments on its debt are not well covered by EBIT (2.9x coverage).